These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 39485844)

  • 1. A dual role for PSIP1/LEDGF in T cell acute lymphoblastic leukemia.
    Demoen L; Matthijssens F; Reunes L; Palhais B; Lintermans B; T'Sas S; Fijalkowski I; Taminau J; Akele MZ; Van Belle S; Taghon T; Deforce D; Van Nieuwerburgh F; Berx G; Ntziachristos P; Debyser Z; Durinck K; Pieters T; Goossens S; Van Vlierberghe P
    Sci Adv; 2024 Nov; 10(44):eado6765. PubMed ID: 39485844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. RUNX2 regulates leukemic cell metabolism and chemotaxis in high-risk T cell acute lymphoblastic leukemia.
    Matthijssens F; Sharma ND; Nysus M; Nickl CK; Kang H; Perez DR; Lintermans B; Van Loocke W; Roels J; Peirs S; Demoen L; Pieters T; Reunes L; Lammens T; De Moerloose B; Van Nieuwerburgh F; Deforce DL; Cheung LC; Kotecha RS; Risseeuw MD; Van Calenbergh S; Takarada T; Yoneda Y; van Delft FW; Lock RB; Merkley SD; Chigaev A; Sklar LA; Mullighan CG; Loh ML; Winter SS; Hunger SP; Goossens S; Castillo EF; Ornatowski W; Van Vlierberghe P; Matlawska-Wasowska K
    J Clin Invest; 2021 Mar; 131(6):. PubMed ID: 33555272
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ZEB2 and LMO2 drive immature T-cell lymphoblastic leukemia via distinct oncogenic mechanisms.
    Goossens S; Wang J; Tremblay CS; De Medts J; T'Sas S; Nguyen T; Saw J; Haigh K; Curtis DJ; Van Vlierberghe P; Berx G; Taghon T; Haigh JJ
    Haematologica; 2019 Aug; 104(8):1608-1616. PubMed ID: 30679322
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ERG promotes T-acute lymphoblastic leukemia and is transcriptionally regulated in leukemic cells by a stem cell enhancer.
    Thoms JA; Birger Y; Foster S; Knezevic K; Kirschenbaum Y; Chandrakanthan V; Jonquieres G; Spensberger D; Wong JW; Oram SH; Kinston SJ; Groner Y; Lock R; MacKenzie KL; Göttgens B; Izraeli S; Pimanda JE
    Blood; 2011 Jun; 117(26):7079-89. PubMed ID: 21536859
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Overexpression of the anti-apoptotic protein AVEN contributes to increased malignancy in hematopoietic neoplasms.
    Eißmann M; Melzer IM; Fernández SB; Michel G; Hrabě de Angelis M; Hoefler G; Finkenwirth P; Jauch A; Schoell B; Grez M; Schmidt M; Bartholomae CC; Newrzela S; Haetscher N; Rieger MA; Zachskorn C; Mittelbronn M; Zörnig M
    Oncogene; 2013 May; 32(20):2586-91. PubMed ID: 22751129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. LEDGF/p75 is dispensable for hematopoiesis but essential for MLL-rearranged leukemogenesis.
    El Ashkar S; Schwaller J; Pieters T; Goossens S; Demeulemeester J; Christ F; Van Belle S; Juge S; Boeckx N; Engelman A; Van Vlierberghe P; Debyser Z; De Rijck J
    Blood; 2018 Jan; 131(1):95-107. PubMed ID: 29084774
    [TBL] [Abstract][Full Text] [Related]  

  • 7. NKX3.1 is a direct TAL1 target gene that mediates proliferation of TAL1-expressing human T cell acute lymphoblastic leukemia.
    Kusy S; Gerby B; Goardon N; Gault N; Ferri F; Gérard D; Armstrong F; Ballerini P; Cayuela JM; Baruchel A; Pflumio F; Roméo PH
    J Exp Med; 2010 Sep; 207(10):2141-56. PubMed ID: 20855495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic dysregulation of ZEB1 is involved in LMO2-promoted T-cell acute lymphoblastic leukaemia leukaemogenesis.
    Wu C; Li J; Tian C; Shi W; Jiang H; Zhang Z; Wang H; Zhang Q; Sun W; Sun P; Xiang R; Yang S
    Biochim Biophys Acta Mol Basis Dis; 2018 Aug; 1864(8):2511-2525. PubMed ID: 29778661
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement for Lyl1 in a model of Lmo2-driven early T-cell precursor ALL.
    McCormack MP; Shields BJ; Jackson JT; Nasa C; Shi W; Slater NJ; Tremblay CS; Rabbitts TH; Curtis DJ
    Blood; 2013 Sep; 122(12):2093-103. PubMed ID: 23926305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PSIP1/p75 promotes tumorigenicity in breast cancer cells by promoting the transcription of cell cycle genes.
    Singh DK; Gholamalamdari O; Jadaliha M; Ling Li X; Lin YC; Zhang Y; Guang S; Hashemikhabir S; Tiwari S; Zhu YJ; Khan A; Thomas A; Chakraborty A; Macias V; Balla AK; Bhargava R; Janga SC; Ma J; Prasanth SG; Lal A; Prasanth KV
    Carcinogenesis; 2017 Oct; 38(10):966-975. PubMed ID: 28633434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disruption of Ledgf/Psip1 results in perinatal mortality and homeotic skeletal transformations.
    Sutherland HG; Newton K; Brownstein DG; Holmes MC; Kress C; Semple CA; Bickmore WA
    Mol Cell Biol; 2006 Oct; 26(19):7201-10. PubMed ID: 16980622
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of PSIP1/LEDGF/p75 in lentiviral infectivity and integration targeting.
    Marshall HM; Ronen K; Berry C; Llano M; Sutherland H; Saenz D; Bickmore W; Poeschla E; Bushman FD
    PLoS One; 2007 Dec; 2(12):e1340. PubMed ID: 18092005
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Embryonic Lethality Due to Arrested Cardiac Development in Psip1/Hdgfrp2 Double-Deficient Mice.
    Wang H; Shun MC; Dickson AK; Engelman AN
    PLoS One; 2015; 10(9):e0137797. PubMed ID: 26367869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the
    Rahman S; Magnussen M; León TE; Farah N; Li Z; Abraham BJ; Alapi KZ; Mitchell RJ; Naughton T; Fielding AK; Pizzey A; Bustraan S; Allen C; Popa T; Pike-Overzet K; Garcia-Perez L; Gale RE; Linch DC; Staal FJT; Young RA; Look AT; Mansour MR
    Blood; 2017 Jun; 129(24):3221-3226. PubMed ID: 28270453
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-7 Functions as a Tumor Suppressor by Targeting the Oncogenes TAL1 in T-Cell Acute Lymphoblastic Leukemia.
    Sun H; Zhang Z; Luo W; Liu J; Lou Y; Xia S
    Technol Cancer Res Treat; 2020; 19():1533033820934130. PubMed ID: 32633635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation of the receptor tyrosine phosphatase PTPRC (CD45) in T-cell acute lymphoblastic leukemia.
    Porcu M; Kleppe M; Gianfelici V; Geerdens E; De Keersmaecker K; Tartaglia M; Foà R; Soulier J; Cauwelier B; Uyttebroeck A; Macintyre E; Vandenberghe P; Asnafi V; Cools J
    Blood; 2012 May; 119(19):4476-9. PubMed ID: 22438252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SQSTM1-NUP214: a new gene fusion in adult T-cell acute lymphoblastic leukemia.
    Gorello P; La Starza R; Di Giacomo D; Messina M; Puzzolo MC; Crescenzi B; Santoro A; Chiaretti S; Mecucci C
    Haematologica; 2010 Dec; 95(12):2161-3. PubMed ID: 20851865
    [No Abstract]   [Full Text] [Related]  

  • 18. TALEN knockout of the PSIP1 gene in human cells: analyses of HIV-1 replication and allosteric integrase inhibitor mechanism.
    Fadel HJ; Morrison JH; Saenz DT; Fuchs JR; Kvaratskhelia M; Ekker SC; Poeschla EM
    J Virol; 2014 Sep; 88(17):9704-17. PubMed ID: 24942577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hhex regulates Kit to promote radioresistance of self-renewing thymocytes in Lmo2-transgenic mice.
    Shields BJ; Alserihi R; Nasa C; Bogue C; Alexander WS; McCormack MP
    Leukemia; 2015 Apr; 29(4):927-38. PubMed ID: 25283843
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic dependency on SWI/SNF chromatin remodeling factors in T-cell acute lymphoblastic leukemia.
    Kim H; Tan TK; Lee DZY; Huang XZ; Ong JZL; Kelliher MA; Yeoh AEJ; Sanda T; Tan SH
    Leukemia; 2024 Sep; 38(9):1906-1917. PubMed ID: 38969731
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.